Your browser doesn't support javascript.
loading
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Barnes, Daniel R; Rookus, Matti A; McGuffog, Lesley; Leslie, Goska; Mooij, Thea M; Dennis, Joe; Mavaddat, Nasim; Adlard, Julian; Ahmed, Munaza; Aittomäki, Kristiina; Andrieu, Nadine; Andrulis, Irene L; Arnold, Norbert; Arun, Banu K; Azzollini, Jacopo; Balmaña, Judith; Barkardottir, Rosa B; Barrowdale, Daniel; Benitez, Javier; Berthet, Pascaline; Bialkowska, Katarzyna; Blanco, Amie M; Blok, Marinus J; Bonanni, Bernardo; Boonen, Susanne E; Borg, Åke; Bozsik, Aniko; Bradbury, Angela R; Brennan, Paul; Brewer, Carole; Brunet, Joan; Buys, Saundra S; Caldés, Trinidad; Caligo, Maria A; Campbell, Ian; Christensen, Lise Lotte; Chung, Wendy K; Claes, Kathleen B M; Colas, Chrystelle; Collonge-Rame, Marie-Agnès; Cook, Jackie; Daly, Mary B; Davidson, Rosemarie; de la Hoya, Miguel; de Putter, Robin; Delnatte, Capucine; Devilee, Peter; Diez, Orland; Ding, Yuan Chun; Domchek, Susan M.
  • Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. drb54@medschl.cam.ac.uk.
  • Rookus MA; The Netherlands Cancer Institute, Department of Epidemiology (PSOE), Amsterdam, The Netherlands.
  • McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Mooij TM; The Netherlands Cancer Institute, Department of Epidemiology (PSOE), Amsterdam, The Netherlands.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Adlard J; Chapel Allerton Hospital, Yorkshire Regional Genetics Service, Leeds, UK.
  • Ahmed M; Great Ormond Street Hospital for Children NHS Trust, North East Thames Regional Genetics Service, London, UK.
  • Aittomäki K; University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
  • Andrieu N; Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.
  • Andrulis IL; Institut Curie, Paris, France.
  • Arnold N; Mines ParisTech, Fontainebleau, France.
  • Arun BK; Department of Life & Health Sciences, PSL University, Paris, France.
  • Azzollini J; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON, Canada.
  • Balmaña J; University of Toronto, Department of Molecular Genetics, Toronto, ON, Canada.
  • Barkardottir RB; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Department of Gynaecology and Obstetrics, Kiel, Germany.
  • Barrowdale D; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Institute of Clinical Molecular Biology, Kiel, Germany.
  • Benitez J; University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX, USA.
  • Berthet P; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Unit of Medical Genetics, Department of Medical Oncology and Hematology, Milan, Italy.
  • Bialkowska K; Vall d'Hebron Institute of Oncology, High Risk and Cancer Prevention Group, Barcelona, Spain.
  • Blanco AM; University Hospital of Vall d'Hebron, Department of Medical Oncology, Barcelona, Spain.
  • Blok MJ; Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.
  • Bonanni B; University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland.
  • Boonen SE; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Borg Å; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Bozsik A; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.
  • Bradbury AR; Centre François Baclesse, Département de Biopathologie, Caen, France.
  • Brennan P; Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.
  • Brewer C; University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA, USA.
  • Brunet J; Maastricht University Medical Center, Department of Clinical Genetics, Maastricht, The Netherlands.
  • Buys SS; IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy.
  • Caldés T; Zealand University Hospital, Clinical Genetic Unit, Department of Paediatrics, Roskilde, Denmark.
  • Caligo MA; Lund University, Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund, Sweden.
  • Campbell I; National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary.
  • Christensen LL; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA, USA.
  • Chung WK; Institute of Genetic Medicine, International Centre for Life, Northern Genetic Service, Newcastle upon Tyne, UK.
  • Claes KBM; Royal Devon & Exeter Hospital, Department of Clinical Genetics, Exeter, UK.
  • Colas C; ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Hereditary Cancer Program, Barcelona, Spain.
  • Collonge-Rame MA; University Hospital, SOD Genetica Molecolare, Pisa, Italy.
  • Cook J; Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
  • Daly MB; The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC, Australia.
  • Davidson R; Aarhus University Hospital, Department of Clinical Medicine,, Aarhus, Denmark.
  • de la Hoya M; Columbia University, Departments of Pediatrics and Medicine, New York, NY, USA.
  • de Putter R; Ghent University, Centre for Medical Genetics, Ghent, Belgium.
  • Delnatte C; Institut Curie, Service de Génétique, Paris, France.
  • Ding YC; CHU de Besançon, Service de Génétique, Besançon, France.
  • Domchek SM; Sheffield Children's Hospital, Sheffield Clinical Genetics Service, Sheffield, UK.
Genet Med ; 22(10): 1653-1666, 2020 10.
Article en En | MEDLINE | ID: mdl-32665703
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article